Growth momentum masks margin compression; near-term freight headwinds vs multi-year EBITDA target
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met prior FY26 guidance on Strontium ramp (₹25 Cr Q1 revenue confirmed). Maintained 20% EBITDA target for FY28 but reduced capex guidance ₹300 Cr → ₹200–250 Cr (capex cut). Prior-year margins not explicitly guided but exceeded 16% EBITDA; Q1 16.1% → 15.1% represents a miss on quality.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong 25% revenue growth and strategic initiatives (DMSO, SA mining, Chrome Oxide Green supply deal) support medium-term 20% EBITDA target, but Q1 margin compression (EBITDA 100 bps YoY decline despite 25% revenue growth) and Q2 freight cost headwinds (~20% vs 9–10% Q1) expose near-term execution risk. Strontium stabilizing slower than hoped; South Africa mining delayed.
₹433.4 Cr
Revenue · +24.9% YoY₹39.6 Cr
Reported PAT · +23% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Delivered over 20% YoY growth in revenue and PAT
METRevenue +24.9% YoY (₹433.4 Cr vs ₹346.9 Cr), PAT +23% YoY (₹39.6 Cr vs ₹32.2 Cr) — claims supported
Underlying strength and resilience despite global uncertainty
OVERSTATEDEBITDA margin 15.1% vs 16.1% YoY (100 bps compression), PAT margin 9.1% vs 9.3% YoY (20 bps compression). One-off ₹8 Cr baryte charge and maintenance shutdown cited, but margins still below prior year
Strontium ramp-up in Q1 FY27 delivering value
PartialStrontium revenue ₹25 Cr achieved. Still in 'stabilization phase' at 50% capacity utilization; gross margins suboptimal, targeting 50%+ but not yet achieved. Yields improving
Barium margins targeting 25% EBITDA moving forward
METBarium standalone at 25% EBITDA (confirmed by management). One-off ₹8 Cr retrospective baryte charge in Q1 masked underlying margin, which management says 'will not recur'. Demand robust, sulphur byproduct values up 300–400%
South Africa mining providing margin uplift in H2 FY27
MISSAcquisition November 2025, refurbishment ongoing. Mgmt: 'expecting production anytime towards end of this month' (August 2026); volumes H2 FY27. Gross margin currently 44–45%, targeting 50%. Analyst Dhimant Shah challenged: 'no improvement visible'; mgmt deferred to 'end of year' for clarity
Freight cost environment manageable
OVERSTATEDQ1 freight 9–10% of revenue; mgmt now guiding Q2 'could be upwards of 20%'. Only partial customer pass-through expected. This is a material near-term headwind not fully baked into guidance
Earnings quality
What changed since the last call
Capex guidance reduced
DowngradePrior ~₹300 Cr FY27 → now ₹200–250 Cr. DMSO ₹205–240 Cr (₹68 Cr spent YTD), chromium ₹50 Cr, barium ₹40 Cr, South Africa ₹20–25 Cr. Reduction reflects scope or timing adjustment, not explicit in call.
Freight cost outlook worsened
DowngradeQ1 guidance: 9–10% of revenue. Q2 revised to 'upwards of 20%'. Geopolitical Red Sea tensions cited. Material near-term margin headwind not flagged in prior call.
Strontium margin timeline extended
DowngradeFY26 call: 'near-term volume increases from Strontium ramp in Q1 FY27.' Delivered: ₹25 Cr revenue but suboptimal margins. Management now: 'by end of year' expect 50% gross margins. Ramp slower than prior guidance.
South Africa mining commercialization delayed
DowngradeAcquisition Nov 2025. Expecting 'anytime towards end of this month' (Aug 2026) production start, H2 volumes. Analyst Dhimant Shah flagged: no visible gross margin uplift yet. Mgmt defensive.
20% EBITDA target maintained
NeutralFY28 consolidated EBITDA margin target of 20% reaffirmed multiple times despite Q1 delivery at 15.1%. Not a raise; not a cut. Consistent with FY26 guidance.
Long-term supply agreement (Chrome Oxide Green)
New10-year binding supply agreement for Chrome Oxide Green with European client (NDA-protected). Management: margin accretive, formula-driven pricing, high visibility. Expected signing imminently. New growth catalyst.
The Q&A
Analyst Dhimant Shah (ITI Mutual Fund) pressed hard on South Africa acquisition thesis: 'when we took over this big asset, the idea was protection on gross margin but nothing is visible.' Management was defensive, deferring margin clarity to year-end. Other analysts questioned freight pass-through, Strontium margin timeline, and capex ROI; management acknowledged challenges but maintained long-term confidence.
Barium margin pressure — Sagar Jethwani, PhillipCapital
AnsweredOne-off ₹8 Cr retrospective baryte price charge (not recurring). Barium standalone targeting 25% EBITDA. Sulphur byproduct values up 300–400%. Demand robust. EU ADD on Chinese vendors adds 4–5% margin benefit (already captured). Freight headwind remains.
Shutdown impact — Rohit Sinha, Sunidhi Securities
AnsweredChromium performed better this quarter due to product mix shift to value-added derivatives (50% vs 40% FY26). Shutdown did not materially impact revenues (inventory covered gap). Margin improvement from mix, not volume lost.
Strontium margin expectations — Ashish Khurana, Ank Capital
PartialStabilization phase; input/output ratios still suboptimal, will improve in quarters to come. Q1 revenue ₹24 Cr nearly full FY26 annual revenue (signal of scale). As chemistry improves and volumes ramp, margins will follow.
South Africa mining benefit — Dhimant Shah, ITI Mutual Fund
PartialNew line of activity; timelines as expected. Acquisition November 2025, 2-month transfer. Refurbishment ongoing. Production 'anytime towards end of this month', volumes H2 FY27. Relative advantage remains vs peers. By end of year, better clarity. Scalability in H2 will prove ROI.
Freight cost pass-through — Mahek Talati, Agility Advisors
DodgedWorking on it; remains challenging and sensitive. Some peers (South Africa, Turkey) less impacted via Cape of Good Hope route. Partial pass-through on certain accounts. Strategy: shift to domestic sales for Q2 to mitigate; dynamic adjustments ongoing.
Revenue growth bridge — Disha, Sapphire Capital
PartialCombination: Strontium operational (new), barium capacity utilization and blended realization improved, chromium product mix shift to higher-value derivatives. Company does not quantify volume vs value split.
Capex breakdown and FY27 spending — Disha, Sapphire Capital
AnsweredTotal ₹200–250 Cr. DMSO ₹205–240 Cr (₹68 Cr spent YTD), Chromium ₹50 Cr, South Africa ₹20–25 Cr, Barium ₹40 Cr (backward integration). DMSO is majority, import replacement solvent for pharma/agro.
Chrome metal and supply agreement — Mahek Talati, Agility Advisors
PartialVery soon announcement (strategic in nature, linked to long-term supply/partnership). This will change product mix and business model. Long-term supply agreement for Chrome Oxide Green already being finalized with European client (NDA). Margin accretive, formula-driven, 10-year visibility.
20% EBITDA target feasibility — Nirali Gopani, Unique PMS
PartialBarium standalone at 25%. Strontium currently EBITDA positive but not at target margins; by end of year expect target levels with volume ramp. Combined barium + strontium (consolidated minus standalone chromium) should exceed 20%. Chromium improving on product mix.
Long-term supply agreement visibility — Siddhartha Mathew
AnsweredFixed volumes for next 10 years specifically for Chrome Oxide Green. Binding supply agreement, exchange plus logistics (not spot/quarterly). Take-or-pay structure; both parties obligated. Lot more strategic vs current spot sales. Margin accretive.
Debt levels — Siddhartha Mathew
AnsweredAs of 31 Mar 2026 (FY26 close): ₹527 Cr total debt (long + short term), debt-to-equity 0.49. Quarterly balance sheet not shared; will update on Q2 results.
Guidance
No FY27 revenue guidance provided
LowManagement explicitly states 'we do not quantify quarterly or yearly guidance'; emphasis on year-on-year momentum instead of quarterly forecasting
Multi-year growth driven by capacity additions (DMSO, SA mining, Strontium, barium integration)
MediumFY27–FY28 capex ₹200–250 Cr targets new specialty chemicals and backward integration; commercialization timelines H2 FY27 → FY28. Organic growth from these drivers expected.
Consolidated EBITDA margin 20% by FY28
MediumLong-term target reaffirmed multiple times (mentioned 8+ times in call). Driven by product mix upgrade, South Africa mining, DMSO, backward integration. No quarterly or FY27 margin target given. Mgmt acknowledged near-term headwinds (freight, macro) may delay path.
Barium EBITDA 25% sustainable (standalone)
HighConfirmed by management. Demand robust, sulphur byproduct values elevated, export-driven. One-off ₹8 Cr baryte charge non-recurring.
Strontium EBITDA margins by end FY27
MediumCurrently in stabilization phase; targeting end-of-year achievement at higher capacity utilization (65–75%). Yield improvements and chemistry optimization ongoing.
Chromium (stand-alone) margin improvement from product mix
MediumShift to higher-value derivatives (50% of sales) contributing to margin improvement visible in Q1. Long-term supply agreement for Chrome Oxide Green (margin accretive) expected to provide sustained visibility. Commodity leather volume being phased down.
FY27 capex ₹200–250 Cr (down from prior ~₹300 Cr)
HighDMSO ₹205–240 Cr majority (₹68 Cr spent YTD); Chromium ₹50 Cr (value-added derivative expansion); Barium ₹40 Cr (backward integration); South Africa ₹20–25 Cr. Solar ₹5–6 Cr + SPV model.
DMSO commercial production FY28
HighCapex on track per plan; construction and equipment implementation progressing. First organic product for company; solvent for pharma/agro; import replacement.
South Africa mining capex modest; majority acquisition already deployed
MediumFY27 spend ₹20–25 Cr for refurbishment/improvements. Acquisition cost sunk (Nov 2025). Production H2 FY27; margin impact dependent on volumes and ore quality alignment.
Risks the call surfaced
Freight cost inflation
HighQ1 9–10% of revenue; Q2 guidance 'upwards of 20%' due to Red Sea geopolitical tensions. Partial customer pass-through. Could compress EBITDA margin by 300–500 bps sequentially if not managed. Management strategy: shift to domestic sales.
South Africa mining integration
HighAcquisition Nov 2025; refurbishment still underway at call date (Aug 3, 2026). Volumes expected H2 FY27 but no fixed timeline. Gross margin currently 44–45%, target 50% by year-end 'ideally' (hard to quantify per mgmt). Analyst Dhimant Shah challenged: 'acquisition thesis is in jeopardy if no margin benefit visible.' Risk: ROI delayed to FY28 or beyond; capital allocation questioned.
Strontium margin ramp delay
MediumQ1 revenue ₹25 Cr (achievement); at 50% capacity utilization; gross margins 'still suboptimal' per mgmt. Management: yields improving, chemistry optimizing, expect normalized margins by end FY27. Risk: margin uplift pushed beyond year-end; capex return on investment (capex for strontium plant) delayed. Full ramp-up to 65–75% utilization and 50%+ gross margin may slip.
Chrome metal and supply agreement execution
MediumManagement promised 'very soon' announcement on chrome metal JV/partnership linked to long-term Chrome Oxide Green supply deal (10-year agreement). Details gated by NDA. Risk: delay in announcement or disappointing terms (lower margin accretion, smaller volumes, longer ramp). Also: technology transfer risk if JV partner is not vetted (mgmt: 'strategic partnership moving forward' but details withheld).
Macro headwinds and commodity pricing
MediumLeather industry demand remains 'challenging' per mgmt. Chrome ore a commodity linked to freight/logistics. Barium linked to infrastructure/real estate cycles in export markets (US, Latin America, Far East). Geopolitical tensions (West Asia) create volatility. Risk: demand softness in H2 FY27 if global growth stalls; pricing power limited on commodity products.
Management
Score 6/10. Confident on strategy and long-term vision but defensive on near-term challenges (freight, SA mining delays). Reiterates 20% EBITDA target repeatedly (positive signal of conviction) but deflects with 'hard to quantify' when pressed on specifics. Transparent on business segmentation and product mix shifts; opaque on new deals (chrome metal, Chrome Oxide Green supply agreement tied up in NDAs). Hedges near-term guidance ('very hard to quantify quarterly impact'). Met prior guidance on Strontium Q1 revenue (₹25 Cr). Capex reduced ₹300 Cr → ₹200–250 Cr (implied downgrade not explicitly acknowledged). South Africa mining integration delayed by 9 months vs implicit prior timelines. Margin compression Q1 (15.1% vs 16.1% YoY) despite 25% revenue growth indicates execution challenges on cost/mix management. On-track on DMSO and barium backward integration projects per timeline.
1 · Q2 FY27 (Aug–Sep 2026)
South Africa mine production start; Chrome Oxide Green long-term supply agreement signing (NDA-gated; strategic tie-up hinted)
2 · H2 FY27 (Oct 2026–Mar 2027)
Chromite ore shipments from South Africa begin; DMSO capex completion; barium backward integration ramp; Strontium capacity ramping to 65–75% utilization. Freight costs expected to normalize.
3 · FY28 (Apr 2027 onwards)
DMSO, Chrome Oxide Green, and South Africa mining all in commercial production. Management targeting 20% consolidated EBITDA margin.
Strontium stabilizing slower than hoped; South Africa mining delayed.
Revenue soars but margins falter; freight shock exposes execution risk
Vishnu Chemicals delivered 24.9% YoY revenue growth and 23% PAT growth — but EBITDA margin contracted 100 bps to 15.1% despite strong volume momentum. The real story: near-term freight cost inflation and product-ramp inefficiencies are eating into quality gains, challenging the company's path to its 20% EBITDA target by FY28.
On the surface, Vishnu Chemicals printed a quarter that looked bulletproof: revenue up nearly 25% YoY, net profit up 23%, and new products (Strontium, South Africa mining) coming online. But look at the operating margin and you find a different story entirely. EBITDA margin fell 100 basis points YoY to 15.1% despite the strong top-line growth — a sign that the company is struggling to convert volume momentum into profit quality. That gap — between headline growth and margin compression — defines the quarter.
What the numbers actually say
₹433.4 Cr
+24.9% YoY (₹346.9 Cr prior year)
15.1%
−100 bps YoY (was 16.1%)
₹39.6 Cr
+23% YoY (₹32.2 Cr prior year)
The revenue mix is driving the growth: Strontium contributed ₹25 crore (a new line hitting its first full quarter at scale), barium segment performed well at near-optimum utilization, and chromium saw a beneficial mix shift toward higher-margin derivatives. But the margin compression isn't a one-off. Management attributed it to three factors: freight costs now running 9–10% of revenue (vs. lower levels prior year), a one-off ₹8 crore retrospective baryte charge in the barium segment, and a scheduled maintenance shutdown at Vizag. Strip out the one-offs and the underlying issue remains — freight inflation and product ramp inefficiencies are eating into the gains.
What management claimed vs. what actually holds up
Delivered over 20% YoY growth in revenue and PAT
Revenue +24.9% YoY (₹433.4 Cr vs ₹346.9 Cr), PAT +23% YoY (₹39.6 Cr vs ₹32.2 Cr). Numbers confirmed.
Supported
Underlying strength and resilience despite global uncertainty
EBITDA margin 15.1% vs 16.1% YoY (−100 bps). One-off ₹8 Cr baryte charge cited, but margins still below prior year. Strength claim overstated.
Overstated
Strontium ramp-up delivering value in Q1 FY27
Strontium revenue ₹25 Cr achieved. Still in stabilization phase at 50% capacity; gross margins suboptimal, targeting 50%+ but not yet achieved. Yields improving.
Partially supported
Barium margins targeting 25% EBITDA moving forward
Barium standalone at 25% EBITDA confirmed. One-off ₹8 Cr retrospective charge non-recurring; demand robust, sulphur byproduct values up 300–400%.
Supported
South Africa mining providing margin uplift in H2 FY27
Acquisition November 2025, refurbishment ongoing. Mgmt expecting production 'anytime towards end of this month' (August 2026). Analyst Dhimant Shah challenged: 'no improvement visible' yet. Mgmt deferred clarity to year-end.
Contradicted
Freight cost environment manageable
Q1 freight 9–10% of revenue; mgmt now guiding Q2 'could be upwards of 20%'. Only partial customer pass-through expected. Material near-term headwind.
Overstated
What changed on this call
Capex guidance reduced ₹300 Cr → ₹200–250 Cr; implies lower confidence in ROI or scope adjustment
Freight cost outlook worsened: Q1 9–10% → Q2 'upwards of 20%' of revenue; geopolitical Red Sea tensions cited
Strontium margin timeline extended: 'by end of year' for target margins, not imminent; ramp slower than prior guidance
South Africa mining commercialization delayed: production 'anytime towards end of this month' (Aug 2026); volumes H2 FY27; analyst skeptical on margin uplift
20% EBITDA target (FY28) maintained, not upgraded; consistent with prior guidance
Long-term Chrome Oxide Green supply agreement (10-year) announced as new strategic catalyst; terms accretive but NDA-gated
The bull-bear ledger
BULL
25% organic revenue growth driven by new capacity (Strontium ₹25 Cr, barium utilization, chromium mix shift). Strategic capex roadmap (DMSO, South Africa mining, chrome metal JV, Chrome Oxide Green 10-year supply deal) positions company for 20% EBITDA by FY28. Backward integration reduces cost vulnerability vs. peers (Chinese, Turkish competitors).
BEAR
100 bps EBITDA compression despite 25% growth signals execution/mix pressure. Freight costs spiking to 20% in Q2 with only partial customer pass-through — near-term margin headwind material (could compress EBITDA 300–500 bps sequentially). Strontium stabilization slower than expected (50% utilization, suboptimal margins). South Africa mining ROI timeline now under scrutiny; analyst Dhimant Shah flagged: 'acquisition thesis in jeopardy if no margin uplift visible.' Capex cut from ₹300 Cr suggests management doubts on planned returns.
HONEST READ
Long-term strategy is credible: the 20% EBITDA target by FY28 has clear drivers (DMSO commercial, SA mining volume ramp, product mix upgrade). But near-term execution is messier than headline growth suggests. The real test is whether management can defend margins during a volume cycle. If Q2 EBITDA stays compressed (even after freight normalization), the 20% target becomes harder to believe. Until then, this is steady-state strategically but operationally under pressure.
Risks, ranked by how much they should concern a holder
1 · Freight cost shock (HIGH severity)
Q1 freight at 9–10% of revenue; Q2 guidance 'could be upwards of 20%' due to Red Sea geopolitical tensions. Partial customer pass-through only. Impact: could compress consolidated EBITDA by 300–500 bps sequentially if not fully offset by mix or volume. Timing of rate normalization uncertain (management says 'medium term'); this is a real near-term margin risk.
2 · South Africa mining integration risk (HIGH severity)
Acquisition November 2025; refurbishment still underway at call date (August 3, 2026). Mgmt saying production 'anytime towards end of this month' (non-committal language). Gross margin currently 44–45%, target 50% 'ideally' by year-end (hard to quantify). Analyst Dhimant Shah pressed hard: 'acquisition thesis is in jeopardy if no margin benefit visible.' Risk: capex return delayed to FY28 or beyond; capital discipline questioned if volumes or margins disappoint.
3 · Strontium margin ramp delayed (MEDIUM severity)
Q1 revenue ₹25 Cr is an achievement, but at only 50% capacity utilization with suboptimal gross margins. Mgmt: 'stabilization phase,' yields improving, expect normalized margins 'by end of year.' Risk: full ramp to target margins pushed beyond FY27; capex return on investment deferred; if yields don't improve as expected, margins stay compressed longer.
4 · Chrome metal & Chrome Oxide Green supply agreement execution (MEDIUM severity)
Management promised 'very soon' announcement on chrome metal JV/partnership. Long-term Chrome Oxide Green supply agreement (10-year, binding, take-or-pay) is accretive but details NDA-gated. Risk: announcements delayed; terms disappoint (lower margin accretion, smaller volumes, longer ramp); technology transfer risk if JV partner is not fully vetted.
5 · Macro and leather industry demand softness (MEDIUM severity)
Management acknowledged chromium commodity segment (base chrome sulphate, sodium dichromate) facing 'challenging' demand from leather industry. Geopolitical and logistics volatility ongoing. Risk: if global growth stalls, demand softness could persist; pricing power limited on commodity products; geographic diversification helps (45% domestic, 55% export) but not immune.
How the street is positioned
The market's day-1 reaction tells you something important: the stock fell 1.78% despite reported PAT growth of 23%. The result was announced on Saturday, August 1, 2026 (close ₹610); by the next trading day, it had fallen to near ₹600. That move — selling into headline growth — signals the street is skeptical about earnings quality and near-term execution. At ₹594.9 (as of August 4), the stock sits 11.18% below its all-time high, but still above its 200-day moving average, suggesting the drawdown is a repricing for execution risk rather than a full capitulation. RSI at 38 is neutral. FII and DII ownership are flat quarter-on-quarter, with promoters stable at 69.21%, indicating no panic selling or insider positioning change.
What to watch next
1 · Q2 EBITDA margin trajectory under the 20% freight regime
The key metric to track. If margin stays at 15% or falls further despite the domestic sales shift and partial freight pass-through, the 20% FY28 target becomes harder to believe. If it recovers to 16%+ by Q2–Q3 (as management hopes), the margin compression story is a near-term blip. This is the number.
2 · South Africa mining production start and gross margin achievement
Q2/Q3 results should show whether production began as promised ('end of August 2026'), volumes ramped to H2 expectations, and gross margin moved toward the 50% target. If nothing is visible by Q2, the analyst skepticism will be validated and the capex thesis will be at risk.
3 · Strontium capacity ramp and margin normalization
Management expects 65–75% capacity utilization by year-end with normalized 50%+ gross margins. Q2/Q3 should show progress on yields, input/output ratios, and utilization. If the ramp stalls or margins remain suboptimal, the Strontium capex return is delayed.
4 · Chrome metal JV and Chrome Oxide Green supply agreement announcements
Timing and terms matter. The Chrome Oxide Green supply deal (10-year, take-or-pay) is strategic and margin-accretive, but the chrome metal partnership is the bigger wildcard. Both are NDA-gated; if they're delayed or terms are lighter than implied, the near-term margin uplift thesis weakens.
The debate
The single number to track
EBITDA margin YoY. If it stays at 15% or declines in Q2 FY27 (even with freight costs moderating), the 20% FY28 target loses credibility. If it recovers to 16%+ by Q2–Q3, the margin compression story was a near-term operational blip and the long-term thesis holds. This is not a technical metric — it's the core of the bull-bear debate. Watch it closely in the Q2 results (expected October 2026).
Vishnu Chemicals is a steady strategic story with messy near-term execution. The company has a clear roadmap to 20% EBITDA by FY28 (DMSO commercial, South Africa mining, product mix upgrade), and the 25% Q1 revenue growth shows the volume momentum is real. But headline growth is masking margin compression that the market has already priced in (day-1 sell-off, 11% drawdown from ATH). Until Q2 results show either margin recovery or visible progress on South Africa/Strontium/chrome metal catalysts, this is a hold — not a sell, but not a buy on momentum either.
The street is right to be cautious. Execution risk is real. Track the EBITDA margin YoY in Q2; that's the number that will either validate or challenge the long-term thesis.
Vishnu Chemicals Q1: consolidated PAT ₹39.6 Cr up 23% YoY, revenue climbs 25% on overseas
PAT +23.02% YoY · revenue +24.93% · margins compressing
₹433.41 Cr
+24.93% YoY
₹39.64 Cr
+23.02% YoY
8.88%
-0.3pp YoY
₹5.89
Vishnu Chemicals opened FY27 with consolidated revenue of ₹433.4 Cr, up 24.9% YoY from ₹346.9 Cr, and net profit of ₹39.6 Cr, up 23.0% from ₹32.2 Cr a year ago (EPS ₹5.89 vs ₹4.79). The growth was almost entirely export-led: overseas sales rose ~52% YoY to ₹239.4 Cr while domestic revenue was broadly flat at ₹192.7 Cr, consistent with management's prior-call thesis of favourable chrome and barium demand in the US and Europe and the Strontium Carbonate ramp flagged for this quarter. On that count the print confirms the confident, growth-oriented guidance given on the Q3 FY26 concall rather than contradicting it.
Q1 FY-2027 vs prior quarters
Profitability, however, grew slightly slower than the topline. PBT actually rose 31.7% YoY to ₹55.1 Cr, but the consolidated tax rate climbed to 28% (from 23% a year ago) and pulled PAT growth down to 23%. Operating margin compressed to roughly 15% from ~16% a year earlier as finance costs jumped to ₹12.1 Cr (from ₹8.4 Cr YoY and just ₹4.9 Cr in Q4) and manufacturing expenses rose; net margin held flat at ~9.1% only because other income more than doubled to ₹12.9 Cr. Sequentially the quarter was softer — revenue -3.8% and PAT -8.7% versus a seasonally strong Q4 FY26 (₹450.3 Cr / ₹43.4 Cr) — but YoY is the cleaner read and it is firmly positive.
The stock went into the print at ₹610, down 3.3% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 3 consecutive quarters.
What the summary numbers don't show
Standalone PAT ₹31.9 Cr (+77% YoY) on revenue ₹297.7 Cr (+13% YoY) — board set Aug 21 dividend record date, Aug 28 AGM
Management guides for sustained growth, expecting near-term volume increases from the ramp-up of Strontium Carbonate in Q1 FY27 and favorable market dynamics for chrome and barium chemicals in the US and Europe. A significant CAPEX plan of approximately 300 crores in FY27 is underway to fund new high-margin products li
— This quarter: met
No brokerage consensus is published for this small-cap, so the print can't be graded against a street number, and there is no formal quantitative revenue/profit guidance on record beyond the FY28 target of a 20% consolidated EBITDA margin — against which this quarter's ~15% shows the gap management intends to close via its ~₹300 Cr FY27 capex (DMSO, capacity, backward integration). Alongside results the board set an August 21 dividend record date and an August 28 AGM. The main watch is whether the sharply higher finance cost is a one-quarter step-up tied to the capex cycle or a structural drag on margins as the spend builds.
W1
Finance cost trajectory — ₹12.1 Cr this quarter (2.5x QoQ); confirm whether it stabilises as the ~₹300 Cr FY27 capex draws down
W2
Strontium Carbonate ramp and export momentum — overseas revenue +52% YoY to ₹239.4 Cr; watch for sustainability next quarter
W3
EBITDA margin progression toward the guided 20% by FY28, from ~15% this quarter
Clean digital filing, both statements in ₹ Lakhs. No exceptional items or NCI (NCI net profit nil). Consolidated tax rate rose to 28% (vs 23% YoY), trimming PAT growth below PBT growth; finance costs jumped to ₹12.1 Cr (+44% YoY, ~2.5x QoQ). One Indian subsidiary + step-down carried net loss of ₹4.20 Cr per auditor note.